Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Russell W. Hinerman is active.

Publication


Featured researches published by Russell W. Hinerman.


Cancer | 2002

Squamous Cell Carcinoma of the Oropharynx Surgery, Radiation Therapy, or Both

James T. Parsons; William M. Mendenhall; Scott P. Stringer; Robert J. Amdur; Russell W. Hinerman; Douglas B. Villaret; Giselle J. Moore-Higgs; Bruce D. Greene; Tod W. Speer; Nicholas J. Cassisi; Rodney R. Million

The treatment of patients with squamous cell carcinoma (SCC) of the oropharynx remains controversial. No randomized trial has addressed adequately the question of whether surgery (S), radiation therapy (RT), or combined treatment is most effective.


Journal of Clinical Oncology | 2001

T1-T2N0 Squamous Cell Carcinoma of the Glottic Larynx Treated With Radiation Therapy

William M. Mendenhall; Robert J. Amdur; Christopher G. Morris; Russell W. Hinerman

PURPOSE The end results after radiation therapy for T1-T2N0 glottic carcinoma vary considerably. We analyze patient-related and treatment-related parameters that may influence the likelihood of cure. PATIENTS AND METHODS Five hundred nineteen patients were treated with radiation therapy and had follow-up for >or= 2 years. Three patients who were disease-free were lost to follow-up at 7 months, 21 months, and 10.5 years. No other patients were lost to follow-up. RESULTS Local control rates at 5 years after radiation therapy were as follows: T1A, 94%; T1B, 93%; T2A, 80%; and T2B, 72%. Multivariate analysis of local control revealed that the following parameters significantly influenced this end point: overall treatment time (P < .0001), T stage (P = .0003), and histologic differentiation (P = .013). Patients with poorly differentiated cancers fared less well than those with better differentiated lesions. Rates of local control with laryngeal preservation at 5 years were as follows: T1A and T1B, 95%; T2A, 82%; and T2B, 76%. Cause-specific survival rates at 5 years were as follows: T1A and T1B, 98%; T2A, 95%; and T2B, 90%. One patient with a T1N0 cancer and three patients with T2N0 lesions experienced severe late radiation complications. CONCLUSION Radiation therapy cures a high percentage of patients with T1-T2N0 glottic carcinomas and has a low rate of severe complications. The major treatment-related parameter that influences the likelihood of cure is overall treatment time.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2002

Malignant tumors of the nasal cavity and paranasal sinuses.

Teri S. Katz; William M. Mendenhall; Christopher G. Morris; Robert J. Amdur; Russell W. Hinerman; Douglas B. Villaret

To evaluate the role of radiation therapy in patients with nasal cavity and paranasal sinus tumors.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2004

Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck

William M. Mendenhall; Christopher G. Morris; Robert J. Amdur; John W. Werning; Russell W. Hinerman; Douglas B. Villaret

The purpose of this study was to analyze the results of radiotherapy (RT) alone or combined with surgery for adenoid cystic carcinoma.


American Journal of Clinical Oncology | 2005

Head and Neck Mucosal Melanoma

William M. Mendenhall; Robert J. Amdur; Russell W. Hinerman; John W. Werning; Douglas B. Villaret; Nancy P. Mendenhall

Purpose:The purpose of this article is to discuss the optimal treatment and outcomes for head and neck mucosal melanoma. Methods:Review the pertinent literature. Results:Head and neck mucosal melanoma is a rare entity comprising less than 1% for all Western melanomas. It usually arises in the nasal cavity, paranasal sinuses, and oral cavity. The optimal treatment is surgery. The likelihood of local recurrence after resection is approximately 50%. Radiotherapy (RT) reduces the likelihood of local failure but probably does not enhance survival, which is primarily impacted by advanced T stage and the presence of regional metastases. The 5-year survival rates vary from approximately 20 to 50%. Although the median time to relapse is roughly 1 year or less, late failures are common and cause-specific survival continues to decline after 5 years. Conclusion:The optimal treatment is surgery. Postoperative RT improves local-regional control but may not impact survival. Definitive RT may occasionally cure patients with unresectable local-regional disease or at least provide long-term palliation.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2004

POSTOPERATIVE IRRADIATION FOR SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY: 35-YEAR EXPERIENCE

Russell W. Hinerman; William M. Mendenhall; Christopher G. Morris; Robert J. Amdur; John W. Werning; Douglas B. Villaret

The purpose of this study was to analyze factors influencing outcome in patients who received postoperative irradiation for advanced squamous cell carcinoma of the oral cavity.


International Journal of Radiation Oncology Biology Physics | 1996

Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience

Douglas A. Fein; W. Robert Lee; Warren R. Amos; Russell W. Hinerman; James T. Parsons; William M. Mendenhall; Scott P. Stringer; Nicholas J. Cassisi; Rodney R. Million

PURPOSE This study was done to determine the outcome in patients with oropharyngeal carcinoma treated at the University of Florida with radiotherapy alone to the primary site, for comparison with reported results of other types of treatment. METHODS AND MATERIALS Of a consecutive cohort of 785 patients with biopsy-proven, previously untreated, invasive squamous cell carcinoma of the oropharynx, this report is based on the 490 patients who had continuous-course irradiation with curative intent at the University of Florida between October 1964 and January 1991. All patients had a minimum 2-year follow-up. Forty-eight percent had Stage T3 or T4 disease, and 64% had clinically apparent neck node metastases. The median radiation dose was 68 Gy for once-a-day treatment and 76.8 Gy for twice-a-day treatment. Patients with advanced neck node disease had planned neck dissection(s) after radiotherapy. RESULTS The overall local control rate after radiotherapy alone was 73%. The ultimate local control rate (including surgical salvage) was 78%. At 5 years, the probability of control of neck disease was 85%; control above the clavicles, 67%; absolute survival, 44%; cause-specific survival, 77%; distant metastasis (as the first or only site of failure), 11%. Thirteen patients (2.6%) experienced severe treatment complications. CONCLUSION Radiotherapy results in tumor control and survival rates comparable with rates achieved with combined irradiation and surgery, with less morbidity.


Cancer | 2003

Breast boost: Are we missing the target?

Rashmi K. Benda; Gopika Yasuda; A. Sethi; Sheryl G.A. Gabram; Russell W. Hinerman; Nancy Price Mendenhall

Randomized trials have shown improved local control with the use of a breast boost for patients given breast‐conserving treatment for breast carcinoma. Although the use of a breast boost is routine practice, no standard technique has been established. The authors compared the commonly used clinical technique with a technique based on computed tomography (CT) imaging of surgical clips in the tumor bed.


Journal of Clinical Oncology | 2000

Is Radiation Therapy a Preferred Alternative to Surgery for Squamous Cell Carcinoma of the Base of Tongue

William M. Mendenhall; Scott P. Stringer; Robert J. Amdur; Russell W. Hinerman; Giselle J. Moore-Higgs; Nicholas J. Cassisi

PURPOSE To evaluate irradiation alone for treatment of base-of-tongue cancer. PATIENTS AND METHODS Two hundred seventeen patients with squamous cell carcinoma of the base of tongue were treated with radiation alone and had follow-up for >/= 2 years. RESULTS Local control rates at 5 years were as follows: T1, 96%; T2, 91%; T3, 81%; and T4, 38%. Multivariate analysis revealed that T stage (P =.0001) and overall treatment time (P =.0006) significantly influenced local control. The 5-year rates of local-regional control were as follows: I, 100%; II, 100%; III, 83%; IVA, 64%; and IVB, 65%. Multivariate analysis revealed that the following parameters significantly affect the probability of this end point: T stage (P =.0001), overall treatment time (P =.0001), overall stage (P =.0131), and addition of a neck dissection (P =.0021). The rates of absolute and cause-specific survival at 5 years were as follows: I, 50% and 100%; II, 81% and 100%; III, 65% and 76%; IVA, 42% and 56%; and IVB, 44% and 52%. Severe radiation complications developed in eight patients (4%). CONCLUSION The likelihood of cure after external-beam irradiation was related to stage, overall treatment time, and addition of a planned neck dissection. The local-regional control rates and survival rates after radiation therapy were comparable to those after surgery, and the morbidity associated with irradiation was less.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2002

Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck

William M. Mendenhall; Douglas B. Villaret; Robert J. Amdur; Russell W. Hinerman; Anthony A. Mancuso

To define the role of planned neck dissection after definitive radiotherapy for patients with node‐positive squamous cell carcinoma of the head and neck.

Collaboration


Dive into the Russell W. Hinerman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Scott P. Stringer

University of Mississippi Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge